璁㈣喘淇℃伅锛欬/span>
鍝佺墝 | 璐у彿 | 鍝佸悕 | 瑙勬牸 | 鐩綍浠?nbsp; | 澶囨敞 |
R&D SYSTEMS | 240-B-002 | Recombinant Human TGF-beta 1 Protein | 2ug | 3502 | 鐜拌揣 |
R&D SYSTEMS | 240-B-010 | Recombinant Human TGF-beta 1 Protein | 10ug | 10938 |
浠嬬粛锛欬/span>
浣滀负鑳炲淇″彿鍒嗗瓙锛孅/span>TGF-beta1铔嬬櫧鍦ㄥ绉嶇粏鑳炰腑杩涜琛ㄨ揪锛屽苟浣滀负鑳炲淇″彿鍒嗗瓙鍙備笌鍏嶇柅鍔熻兘锛岀粏鑳炲娈栧拰缁嗚優鍒嗗寲绛夌敓鐗╁杩囩▼銆?985骞达紝浣滀负鍏徃鎺ㄥ嚭鐨勭涓€涓鐮旇瘯鍓備骇鍝侊紝涔熸槸鍏ㄧ悆绗竴瀹跺皢璇ヤ骇鍝佽繘琛屽晢涓氬寲鐢熶骇鐨勪骇鍝侊紝R&D Systems鎴愬姛涓婂競浜員GF-beta1铔嬬櫧銆侟/span>
Purity | >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie庐 Blue Staining. |
Endotoxin Level | <0.10 EU per 1 渭g of the protein by the LAL method. |
Activity | Measured by its ability to inhibit the IL-4-dependent proliferation of HT 2 mouse T cells. Tsang, M.et al. (1995) Cytokine 7:389. The ED50 for this effect is 0.04-0.2 ng/mL. The specific activity of Recombinant Human TGF-beta 1 is approximately 2.5 x 104 U/渭g, which is calibrated against human TGF beta 1 Standard (NIBSC code: 89/514). |
Source | Chinese Hamster Ovary cell line, CHO-derived human TGF-beta 1 protein Ala279-Ser390 |
Accession # | P01137 |
N-terminal Sequence Analysis | Ala279 |
Structure / Form | Disulfide-linked homodimer |
Predicted Molecular Mass | 12.8 kDa (monomer) |
SDS-PAGE | 12 kDa, reducing conditions |
24 kDa, non-reducing conditions |
3504420063
wxid_vlsnxw33sd0622
0731-84321919
